Dr. Diana Girnita explains ankylosing spondylitis treatments, including NSAIDs, biologics, and the importance of exercise for managing symptoms.
Key Takeaways
- AS is a chronic, non-curable inflammatory arthritis requiring ongoing management.
- NSAIDs and biologics are effective treatments to control symptoms and inflammation.
- Exercise is a critical component of treatment to maintain mobility and reduce symptoms.
- Untreated AS can cause severe physical disability and increased risk of cardiovascular disease.
- Medical guidance from a rheumatologist is essential for optimal treatment selection.
Summary
- Ankylosing spondylitis (AS) affects about 3.2 million adults in the US and is a chronic inflammatory arthritis impacting the spine, joints, and other organs.
- Early diagnosis is crucial but often delayed; this video focuses on treatment options after diagnosis.
- NSAIDs are the first-line treatment, providing symptom relief for 70-80% of patients; examples include naproxen, diclofenac, meloxicam, and celecoxib.
- Biologic medications target inflammatory proteins TNF-alpha and IL-17, with TNF inhibitors like adalimumab and etanercept commonly used, and IL-17 inhibitors like secukinumab as alternatives.
- AS is not curable but treatment aims to halt disease progression and prevent joint and spinal damage.
- Untreated AS can lead to severe complications such as spinal ankylosis, hip arthritis, kyphosis, osteoporosis, fractures, and increased cardiovascular risks.
- Exercise, including range of motion, stretching, and aquatic therapy, is essential in managing AS and should be guided by a physical therapist.
- Spinal manipulation is contraindicated in patients with spinal fusion or advanced osteoporosis.
- Lifestyle factors like smoking and associated conditions (psoriasis, inflammatory bowel disease) influence disease outcomes.
- Consultation with a rheumatologist is recommended for personalized treatment plans.











